Clinical Trial Update: Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies

View source ↗

Summary

A clinical trial evaluating the EZH2 inhibitor tazemetostat in adults with follicular lymphoma who have received at least two prior therapies; the study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• TAZVERIK (TAZEMETOSTAT)

Snippet

Sponsor: Ipsen | Conditions: Follicular Lymphoma | Status: NOT_YET_RECRUITING